organ
patient
inflammatori
bowel
diseas
ibd
invit
follow
nation
recommend
person
unclear
whether
aggress
clinic
cours
might
develop
asymptomat
infect
subject
biolog
therapi
current
evid
support
treatment
suspens
howev
pandem
start
treatment
immunosuppress
drug
biolog
postpon
whenev
possibl
base
individu
risk
assess
clinic
condit
diseas
activ
allow
treatment
delay
start
biolog
therapi
screen
ibd
patient
activ
infect
rtpcr
advis
even
absenc
clinic
suspicion
serum
antibodi
test
avail
could
provid
evid
infect
well
identifi
patient
alreadi
immun
diseas
coronaviru
diseas
recent
classifi
pandem
infect
world
health
organ
present
differ
clinic
manifest
asymptomat
carrier
state
acut
respiratori
diseas
pneumonia
adult
repres
popul
highest
infect
rate
sever
clinic
cours
death
like
older
patient
underli
comorbid
compar
mild
case
also
male
gender
seem
higher
risk
morbid
mortal
due
rapid
spread
diseas
govern
medic
commun
take
measur
prevent
transmiss
common
sens
recommend
radic
quarantin
measur
accumul
evid
show
patient
infect
may
also
experi
gastrointestin
symptom
includ
diarrhea
nausea
vomit
abdomin
discomfort
prior
common
respiratori
symptom
current
recommend
suggest
postpon
start
treatment
immunosuppress
drug
biolog
whenev
possibl
base
individu
risk
assess
pandem
howev
sinc
postpon
drug
start
alway
possibl
depend
clinic
activ
patient
particular
measur
consid
order
reduc
risk
viral
screen
commonli
suggest
start
biolog
due
higher
risk
seriou
opportunist
infect
ibd
patient
becom
particularli
high
patient
older
year
sinc
expect
higher
risk
might
occur
believ
least
temporarili
urgent
need
updat
current
recommend
prebiolog
screen
knowledg
viru
dynam
host
respons
crucial
fulli
evalu
impact
immunosuppress
therapi
clinic
cours
ibd
patient
provid
manag
guidanc
healthcar
profession
conclus
start
biolog
therapi
new
data
avail
use
pragmat
approach
physician
screen
patient
activ
rtpcr
even
without
clinic
suspicion
infect
thu
suggest
updat
common
screen
recommend
prior
biolog
therapi
ibd
patient
declar
compet
interest
